Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I just happened to read your post and I can give you some information. Dr Moro of Biocurex is indeed one of the best con men around. His connection with Trent Davis came via Denis Burger, also of Portland. burger was taken in by Moro, hook line and sinker. Burger was a director of Paulson Capital and managed to have them do a 6 million public offering for Moro. Moro managed to milk millions of the money that Paulson raised to his own company, Pacific biosciences.
I more or less regard Trent Davis of Paulson Capilal a guiltly victim. Once he found it was a scam, he did not come clean with his investors and they all lost tons of money.
It looks like Dr Moro's latest scam may involve this:
"Ricardo Moro-Vidal is the President & Chief Executive Officer at Agoracom based in Richmond Hill, Ontario. Previously, Ricardo was the President at Pacific BioSciences Research Centre "
I know that Moro wanted to control information about Biocurex and used Agoracom to accomplish that. I cannot verify the above quote that I found but I do know that as a con man, Moro has no limits.
hello gold seeker,
would you happen to know this person and what role if any they had in this company?
https://www.sec.gov/Archives/edgar/data/1092562/000100487811000257/xslF345X02/primary_doc.xml
A fast talking con man can take advantage of a lot of people. I look back on this and everything was there to see. The company was set up as a scam by Wittenberg and his group of 52. I was naïve to think that Moro was an innocent victim of the initial scam. He agreed to it all. The rumor from Abbott was that he faked the data on prostate cancer. Obviously Frost got caught up believing in RECAF and that led to more people getting hurt.
At least he is no longer going to ISOBM medical meetings with real researchers and is no longer on their board. Unfortunately, he walked with a lot of investor money via the rebates from Revenue Canada. We can thank Richard Smithline for finally driving the last nail in the biocurex coffin. Smithline could have taken Moro's offer and sold shares to cover some of his losses but Smithline didn't want any more people hurt. He wanted the scam to end. Thank you Richard Smithline.
As most of you know, Moro thought I was his worst enemy but in reality, the truth was his worst enemy.
For anyone who still owned shares of BioCurex on the date of the revocation, you can now deduct those losses on your 2014 tax return. You can deduct your losses on the shares you held on that day. If you are ever audited about the write off, just be sure to present a copy of the SEC final notice of revocation. That should be clear proof it was a worthless stock.
http://www.sec.gov/litigation/admin/2014/34-73872.pdf
It's all over. The scam is dead.
Final Decision REVOKED
UNITED STATES OF AMERICA
before the
SECURITIES AND EXCHANGE COMMISSION
SECURITIES EXCHANGE ACT OF 1934
Release No. 73872 / December 18, 2014
Admin. Proc. File No. 3-16052
In the Matter of
ASIA CORK, INC.,
BIOCUREX, INC.,
CURRENT TECHNOLOGY CORP.,
GLOBETECH VENTURES CORP., and
PEPPER ROCK RESOURCES CORP.
NOTICE THAT INITIAL DECISION HAS BECOME FINAL
The time for filing a petition for review of the initial decision in this proceeding has
expired. No such petition has been filed by Asia Cork, Inc., Biocurex, Inc., Current Technology
Corp., Globetech Ventures Corp., or Pepper Rock Resources Corp. and the Commission has not
chosen to review the decision on its own initiative.
Accordingly, notice is hereby given, pursuant to Rule 360(d) of the Commission's Rules
of Practice,1 that the initial decision of the administrative law judge2 has become the final
decision of the Commission with respect to Asia Cork, Inc., Biocurex, Inc., Current Technology
Corp., Globetech Ventures Corp., and Pepper Rock Resources Corp. The order contained in that
1 17 C.F.R. § 201.360(d).
2 Asia Cork, Inc., Biocurex, Inc., Carthew Bay Technologies, Inc., Current Tech. Corp.,
Gamecorp Ltd. (n/k/a DealNet Capital Corp.), Globetech Ventures Corp., and Pepper Rock Res.
Corp., Initial Decision Rel. No. 686 (Oct. 7, 2014), 109 SEC Docket 19, 2014 WL 4980875.
The stock symbols and Central Index Key numbers are: AKRK and 1104040 for Asia Cork, Inc.;
BOCX and 1092562 for Biocurex, Inc.; CRTCF and 883907 for Current Technology Corp.;
GTVCF and 947994 for Globetech Ventures Corp.; and PEPR and 1448242 for Pepper Rock
Resources Corp.
2
decision is hereby declared effective. The initial decision ordered that, pursuant to Section 12(j)
of the Securities Exchange Act of 1934, the registrations of each class of registered securities of
Asia Cork, Inc., Biocurex, Inc., Current Technology Corp., Globetech Ventures Corp., and
Pepper Rock Resources Corp. are hereby revoked.
For the Commission, by the Office of the General Counsel, pursuant to delegated
authority.
Brent J. Fields
Secretary
Initial decision to revoke the registration has been made. The decision will be served and if no response is made, 21 days later, it will be finalized.
It is now approaching the finalization date.
ORDER
It is ORDERED that, pursuant to Section 12(j) of the Securities Exchange Act of 1934,
the registrations of each class of registered securities of Asia Cork, Inc., Biocurex, Inc., Current
Technology Corp., Globetech Ventures Corp., and Pepper Rock Resources Corp. are hereby
REVOKED.
This Initial Decision shall become effective in accordance with and subject to the
provisions of Rule 360, 17 C.F.R. § 201.360. Pursuant to that Rule, a party may file a petition
for review of this Initial Decision within twenty-one days after service of the Initial Decision. A
party may also file a motion to correct a manifest error of fact within ten days of the Initial
Decision, pursuant to Rule 111, 17 C.F.R. § 201.111(h). If a motion to correct a manifest error
5
of fact is filed by a party, that party shall have twenty-one days to file a petition for review from
the date of the undersigned’s order resolving such motion to correct a manifest error of fact.
This Initial Decision will not become final until the Commission enters an order of finality.
The Commission will enter an order of finality unless a party files a petition for review or a motion
to correct a manifest error of fact or the Commission determines on its own initiative to review the
Initial Decision as to a party.
Revoke not final yet. It will be final in another week. If you get stuck with shares, it will be difficult to take a tax loss because the shares cannot be traded and you have to prove to the IRS that it is a worthless stock. Check with your broker on how to be sure you can take the tax loss.
Moro's scam is now dead and buried. Unfortunately, he pocketed a ton of money from Revenue Canada and is probably now laughing at us.
BioCurex ---- REVOKED.
That's the end of the story. The SEC finally acted.
ORDER
It is ORDERED that, pursuant to Section 12(j) of the Securities Exchange Act of 1934,
the registrations of each class of registered securities of Asia Cork, Inc., Biocurex, Inc., Current
Technology Corp., Globetech Ventures Corp., and Pepper Rock Resources Corp. are hereby
REVOKED.
It is ORDERED that the hearing scheduled to begin on September 26, 2014, is
POSTPONED and a telephonic prehearing conference shall be held on Friday, October 3,
2014, at 11:00 a.m. EDT. Respondents that fail to file Answers by September 22, 2014,
fail to appear at the prehearing conference, or fail to otherwise defend the proceeding
may be deemed in default. OIP at 4; 17 C.F.R. §§ 201.155(a), .220(f).
_______________________________
James E. Grimes
Administrative Law Judge
Thanks, Gold Seeker!
I_Invest, the SEC is just extremely slow to act on anything.
It was interesting that at the bottom of one of the SEC notices was a phone number for Enforcement regarding BioCurex. I called, left my number and was called back the following day. I gave him everything I knew including the crooked stock scam Wittenberg was running. He also said that Revenue Canada would be interested in the R&D credits that Moro personally pocketed.
BioCurex was served notice by mail so that would not go anywhere. In the near future, a hearing will be held and will result in the revocation of the registration.
The stock has not traded since the suspension so maybe the SEC has continued the suspension. It is indeed amazing that people were still buying the worthless shares and obviously doing no DD at all.
i am quite amazed that this stock was listed on an exchange for this long after the complete collapse of the company.
ADMINISTRATIVE PROCEEDINGS RULINGS
Release No. 1819/September 19, 2014
ADMINISTRATIVE PROCEEDING
File No. 3-16052
In the Matter of
ASIA CORK, INC.,
BIOCUREX, INC.,
CARTHEW BAY TECHNOLOGIES, INC.,
CURRENT TECHNOLOGY CORP.,
GAMECORP LTD. (n/k/a DEALNET CAPITAL CORP.),
GLOBETECH VENTURES CORP., and
PEPPER ROCK RESOURCES CORP.
ORDER POSTPONING
HEARING AND
SCHEDULING
PREHEARING
CONFERENCE
On September 4, 2014, the Securities and Exchange Commission issued an Order
Instituting Proceedings (OIP) pursuant to Section 12(j) of the Securities Exchange Act of
1934, alleging that Respondents have securities registered with the Commission and are
delinquent in their periodic filings. A hearing is currently scheduled for Friday,
September 26, 2014.
On September 10 and September 12, 2014, the Division of Enforcement filed
declarations establishing that Respondents were served with the OIP by September 9,
2014, in accordance with Commission Rule of Practice 141(a)(2)(ii). See 17 C.F.R. §
201.141(a)(2)(ii). I find that Respondents were served on September 9, 2014, and
therefore their Answers are due by Monday, September 22, 2014, as service was effected
by mail. OIP at 4; 17 C.F.R. §§ 201.160(b), .220(b).
It is ORDERED that the hearing scheduled to begin on September 26, 2014, is
POSTPONED and a telephonic prehearing conference shall be held on Friday, October 3,
2014, at 11:00 a.m. EDT. Respondents that fail to file Answers by September 22, 2014,
fail to appear at the prehearing conference, or fail to otherwise defend the proceeding
may be deemed in default. OIP at 4; 17 C.F.R. §§ 201.155(a), .220(f).
_______________________________
James E. Grimes
Administrative Law Judge
SECURITIES AND EXCHANGE COMMISSION
SECURITIES EXCHANGE ACT OF 1934
Release No. 73158 / September 22, 2014
ADMINISTRATIVE PROCEEDING
File No. 3-16052
In the Matter of
Asia Cork, Inc.,
Biocurex, Inc.,
Carthew Bay Technologies Inc.,
Current Technology Corp.,
Gamecorp Ltd.
(n/k/a DealNet Capital Corp.),
Globetech Ventures Corp., and
Pepper Rock Resources Corp.,
Respondents.
ORDER MAKING FINDINGS AND
REVOKING REGISTRATION OF
SECURITIES PURSUANT TO
SECTION 12(j) OF THE
SECURITIES EXCHANGE ACT OF
1934 AS TO GAMECORP LTD. (n/k/a
DEALNET CAPITAL CORP.)
I.
The Securities and Exchange Commission (“Commission”) deems it necessary and
appropriate for the protection of investors to accept the Offer of Settlement submitted by
Gamecorp Ltd. (n/k/a DealNet Capital Corp.) (“GAIMF” or “Respondent”) pursuant to Rule
240(a) of the Rules of Practice of the Commission, 17 C.F.R. § 201.240(a), for the purpose of
settlement of these proceedings initiated against Respondent on September 4, 2014, pursuant to
Section 12(j) of the Securities Exchange Act of 1934 (“Exchange Act”).
II.
Solely for the purpose of these proceedings and any other proceedings brought by or on
behalf of the Commission, or to which the Commission is a party, and without admitting or
denying the findings herein, except as to the Commission’s jurisdiction over it and the subject
matter of these proceedings, which are admitted, Respondent consents to the entry of this Order
Making Findings and Revoking Registration of Securities Pursuant to Section 12(j) of the
Securities Exchange Act of 1934 as to Gamecorp Ltd. (n/k/a DealNet Capital Corp.) (“Order”),
as set forth below."
Gamecorp agreed to the revocation but since the SEC would not have been able to contact Moro, this will go to a hearing in 90 days with revocation at that time.
UNITED STATES OF AMERICA
Before the
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
ADMINISTRATIVE PROCEEDINGS RULINGS
Release No. 1762/September 5, 2014
ADMINISTRATIVE PROCEEDING
File No. 3-16052
In the Matter of
ASIA CORK, INC.,
BIOCUREX, INC.,
CARTHEW BAY TECHNOLOGIES, INC.,
CURRENT TECHNOLOGY CORP.,
GAMECORP LTD. (n/k/a DEALNET CAPITAL CORP.),
GLOBETECH VENTURES CORP., and
PEPPER ROCK RESOURCES CORP.
ORDER SCHEDULING
HEARING AND
DESIGNATING
PRESIDING JUDGE
The Securities and Exchange Commission (Commission) has ordered, pursuant to
Rule 360(a)(2) of the Commission’s Rules of Practice, that the Administrative Law Judge
assigned to this proceeding shall issue an initial decision no later than 120 days from
service of the Order Instituting Proceedings. See 17 C.F.R. § 201.360(a)(2).
IT IS ORDERED that the hearing in this matter commence at 9:30 a.m., Friday,
September 26, 2014, in the Commission Headquarters Offices, Hearing Room 2, 100 F
Street, N.E., Washington, D.C. 20549.
IT IS FURTHER ORDERED that Administrative Law Judge James E. Grimes
preside at the hearing in these proceedings and perform other and related duties in
accordance with the Commission’s Rules of Practice.
IT IS FURTHER ORDERED that the parties confer and notify the presiding
judge of a suggested date and time for a prehearing conference which will be conducted
telephonically unless the parties prefer otherwise.
Service of all orders and rulings on parties is made by the Office of the Secretary,
or other duly authorized Commission officer, pursuant to Commission Rule of Practice
141. See 17 C.F.R. § 201.141. All issuances by Administrative Law Judges and other
documents of importance are posted on the Commission’s web site at
http://www.sec.gov/litigation/apdocuments/ap-open-fileno-asc.xml.
For the Commission, by its Chief Administrative Law Judge, pursuant to
delegated authority.
_______________________________
Brenda P. Murray
Chief Administra
Thank you SEC. It is about time Biocurex is shut down from trading.
Moro is certainly not paying anything to keep the scam going. He has even allowed Texas to void the corporation.
BOCX SEC Suspension:
http://www.sec.gov/litigation/suspensions/2014/34-72978.pdf
Order:
http://www.sec.gov/litigation/suspensions/2014/34-72978-o.pdf
Admin Proceeding:
http://www.sec.gov/litigation/admin/2014/34-72979.pdf
Half full, I certainly agree with that.
Colorado becomes first state to approve bill giving terminally ill access to experimental medication
FoxNews.com
Published May 18, 2014
Colorado became the first state to allow terminally ill patients to have access to experimental medicine not yet approved by the FDA Saturday.
Gov. John Hickenlooper signed the so-called 'right to try' bill into law in Fort Collins. The bill's co-sponsor, Democratic State Rep. Joann Ginall, was absent from the signing ceremony in order to tend to her older brother Tom, who is suffering from a rare blood cancer.
"Thank you to everyone for passing this bill, which may bring hope to people like Tom when all else failed," Ginal said in a statement read by State Rep. Randy Fischer at the ceremony. "The types of treatments envisioned in this bill gave my brother more time and hopefully will do the same for others."
The bill allows patients and doctors to work together to secure experimental treatments with the permission of a pharmaceutical company. Insurance companies are not required to pay for the treatment, and drug manufacturers can choose whether to charge for the medication or to provide it to the patient free of charge.
Lawmakers in Missouri and Louisiana have passed similar bills unanimously in recent days, while voters in Arizona will weigh that state's version of the law at the polling place this November.
Supporters of the bills say that they would help patients who are desperate for treatment avoid the lengthy process of getting the FDA to approve access to experimental drugs. Opponents say that the legislation circumvents federal law and undermines the drug development process.
Interesting, I missed the mention of BioCurex in the article. What I just noticed was the PAST TENSE in "was a director of BioCurex". There has never been an 8K saying Burger has resigned even though everyone is gone.
Moro has let the peptide patent expire for lack of a response. In any case, all the patents have been assigned to Centercourt and the other two funds run by Smithline. All of BioCurex's assets have been seized including all of the lab equipment. Their previous building is now a DNA testing company.
Burger attempted to put something together to keep Biocurex running about a year ago but was wanting Smithline to extend the debt. Smithline refused. Someone else attempted to take over the shell but wanted Smithline to take stock in a new company to cover his notes. Smithline refused. Smithline considers Moro to be a scam artist and is tired of hearing all the lies because nothing Moro ever told him was accurate. Smithline decided to shut Moro down and take everything even if it cost him money. That is how much Smithline disliked Moro.
Moro pocketed at least 1.7 million from Revenue Canada to compensate for R&D that had been paid for by BioCurex.
Well you are wrong on all counts. Burgers name was mentioned as a director of Biocurex in the article.
Mr. Trent Davis, CEO, stated, "We are pleased to have Dr. Burger return to the Company's Board, of which he was a member from 2008 to 2010." From 1991-2011, he was managing director of Sovereign Ventures, LLC, a biotech investing and consulting firm. He was a director of BioCurex, Inc.,
Also 800k traded back in May for $.04 and the stock as been trading ever since. Who ever owns the patents isn't going to sit on them they will be sold off. Oncopet was a viable product and the plan was for Burger to take it to the next level and make it a point of care.
Prior to yesterday, this stock was selling for a penny. What happened was the news story about Paulson Capital and the old 2012 news of a loan from Paulson popped up on the BioCurex board. Some people must have thought that was recent news. Paulson gave Moro that money to pay off a death spiral note that was due. The money didn't even pay off the note. It was a total waste by Paulson. Moro was running a scam.
Also, did you notice that BioCurex was totally omitted from Burger's bio?.
All of the patents are owned by Centercourt as well as taking most of the lab equipment. They were seized on the loan default.
There are no assets left in Biocurex.
Only fools are buying this stock. Centercourt was offered stock in a new company who was interested in the shell but Smithline just wanted cash and be done with it. Smithline who runs Centercourt was totally fed up with the likes of Moro.
The shell is now getting stale and probably has little value at all.
I suspect Burger is buying up all the shares and getting ready to sell off all the patents and along with the stock to recoup losses. Why else would it be trading for 12 cents.
Interesting article. Paulson was obviously not well run but I am totally shocked they appointed Burger back as a director. He is the dummy who threw all the money at BioCurex and lost it all.
Moro has abandoned the patent application for the peptide.
20120270238
11-06-2013 ABN Abandonment PROSECUTION
BioCurex is out of business and all assets have been seized by the primary lender.
It is difficult to imagine why a company that is out of business with all assets seized would be trading at all. Finally, in the past two days, the trading price has dropped to a penny a share but that is still ridiculous.
Total Assignments: 4
Patent #:
NONE
Issue Dt:
Application #:
11811590
Filing Dt:
06/11/2007
Publication #:
20070237760
Pub Dt:
10/11/2007
Inventor:
Ricardo J. Moro
Title:
Detection and treatment of cancer
Assignment: 1
Reel/Frame:
022896/0383 Recorded: 07/01/2009 Pages: 2
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
MORO, RICARDO J.
Exec Dt:
06/11/2009
Assignee:
WHISPERING OAKS INTERNATIONAL, INC. D/B/A BIOCUREX, INC.
7080 RIVER ROAD, SUITE 215
RICHMOND, BRITISH COLUMBIA, CANADA V6X 1X5
Correspondent:
MICHAEL LOEW
C/O CENTRECOURT ASSET MANAGEMENT
350 MADISON AVENUE
NEW YORK, NEW YORK 10017
Assignment: 2
Reel/Frame:
022896/0330 Recorded: 07/01/2009 Pages: 4
Conveyance:
SECURITY AGREEMENT
Assignor:
WHISPERING OAKS INTERNATIONAL, INC. D/B/A BIOCUREX, INC.
Exec Dt:
06/16/2009
Assignee:
CAMOFI MASTER LDC
350 MADISON AVENUE
C/O CENTRECOURT ASSET MANAGEMENT
NEW YORK, NEW YORK USA 10017
Correspondent:
MICHAEL LOEW
C/O CENTRECOURT ASSET MANAGEMENT
350 MADISON AVENUE
NEW YORK, NY 10017
Assignment: 3
Reel/Frame:
030034/0160 Recorded: 03/18/2013 Pages: 2
Conveyance:
CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Assignor:
WHISPERING OAKS INTERNATIONAL, INC.
Exec Dt:
10/27/2009
Assignee:
BIOCUREX, INC
7080 RIVER ROAD, SUITE 215
RICHMOND, BRITISH COLUMBIA, CANADA V6X 1X5
Correspondent:
MILTON SPRINGUT LAW PC
75 ROCKFELLER PLAZA, 19FL
NEW YORK, NY 10019
Assignment: 4
Reel/Frame:
030038/0042 Recorded: 03/19/2013 Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
BIOCUREX, INC.
Exec Dt:
03/15/2013
Assignees:
CAMOFI MASTER LDC
C/O CENTER COURT ASSET MANAGEMENT, LLC
11 EAST 44TH STREET, SUITE 1600
NEW YORK, NEW YORK 10017
CAMHZN MASTER LDC
C/O CENTER COURT ASSET MANAGEMENT, LLC
11 EAST 44TH STREET, SUITE 1600
NEW YORK, NEW YORK 10017
Correspondent:
SPRINGUT LAW PC
75 ROCKFELLER PLAZA, 19FL
NEW YORK, NY 10019
Total Assignments: 3
Patent #:
NONE
Issue Dt:
Application #:
13502306
Filing Dt:
04/16/2012
Publication #:
20120270238
Pub Dt:
10/25/2012
Inventors:
Ricardo J. Moro, Ralph H. Schmid
Title:
Peptides That Bind the Alpha-Fetoprotein (AFP) Receptor and Uses Thereof
Assignment: 1
Reel/Frame:
030031/0874 Recorded: 03/18/2013 Pages: 22
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
MORO, RICARDO, DR.
Exec Dt:
10/01/2009
Assignee:
WHISPERING OAKS INTERNATIONAL, INC.
7080 RIVER ROAD, SUITE 215
RICHMOND, BRITISH COLUMBIA, CANADA V6X 1X5
Correspondent:
MILTON SPRINGUT
75 ROCKFELLER PLAZA, 19FL
NEW YORK, NY 10019
Assignment: 2
Reel/Frame:
030034/0160 Recorded: 03/18/2013 Pages: 2
Conveyance:
CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Assignor:
WHISPERING OAKS INTERNATIONAL, INC.
Exec Dt:
10/27/2009
Assignee:
BIOCUREX, INC
7080 RIVER ROAD, SUITE 215
RICHMOND, BRITISH COLUMBIA, CANADA V6X 1X5
Correspondent:
MILTON SPRINGUT LAW PC
75 ROCKFELLER PLAZA, 19FL
NEW YORK, NY 10019
Assignment: 3
Reel/Frame:
030038/0042 Recorded: 03/19/2013 Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
BIOCUREX, INC.
Exec Dt:
03/15/2013
Assignees:
CAMOFI MASTER LDC
C/O CENTER COURT ASSET MANAGEMENT, LLC
11 EAST 44TH STREET, SUITE 1600
NEW YORK, NEW YORK 10017
CAMHZN MASTER LDC
C/O CENTER COURT ASSET MANAGEMENT, LLC
11 EAST 44TH STREET, SUITE 1600
NEW YORK, NEW YORK 10017
Correspondent:
SPRINGUT LAW PC
75 ROCKFELLER PLAZA, 19FL
NEW YORK, NY 10019
I contacted the lender who seized the assets several months ago. Nothing is left of the business. He had interest in the shell but apparently, they were not interested in paying cash for his note. The shell actually would have no value unless his note is resolved. Even if someone takes what is left of the company into bankruptcy, his note still has to be resolved.
Moro apparently made several offers to pay him in shares but he said that he was fed up with being jerked around by Moro and just took all the assets.
Their website was taken down when they closed the Pacific BioSciences lab. They also took down the "dog RECAF" site. Nothing more is going to happen with bioCurex except maybe a reverse merger of some sort with the shell.
Finally - if you check out the weekly I think it shows the story -
Also - their website seems to be in the process of a remodel -
I will be watching this week -
Something is happening behind the scenes here - might see a pump on this IMO -
Yes, as far as BioCurex is concerned, yes it is dead. The company is no longer is business and the last trading appeared to be someone interested in the shell. There may be a reverse merger in the future with another company.
Is this a dead stock?
His phone lines still have the taped message about closing "some" of their facilities. Since he is continuing to pay for those phone lines, I still wonder what he is up to and will hang around if he attempts another scam startup.
Also, whoever bought all those shares owns close to 50% of the stock but they did not file a form 13 with the SEC.
i am surprised you made it back here...
bioCurex used to be on the below website but it looks like Moro is not even attempting to sell the product out of his garage.
http://www.butlerschein.com/home/featured-vendors/vendor-partners
It is clear that the party interested in the shell wants a majority position. He has almost a million shares so he needs about 300,000 more to control the company. If he pays 10 cents a share, it will cost him another $30,000.
At this point, if I had shares, I would not be selling them. Whatever he is going to do with the company, the shares will be worth more than 10 cents.
The main lender is currently owed about $750,000 and Asher is owed about $40,000. When the new owner of the shell takes over, those debts still have to be resolved so it would appear that the total cost of the shell and control will add up to about a million bucks.
This is certainly interesting to see what he is going to do with the shell.
More buying today -
None of todays trades were unresolved so the shares are coming from the open market and not Asher. A total of 835,000 shares traded so the buyers for the shell got 1/3 of the company today.
Followers
|
80
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
30387
|
Created
|
04/11/04
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |